Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chondrodysplasia punctata, Toriello type is a rare, non-rhizomelic, primary bone dysplasia syndrome characterized by calcific stippling of epiphyses in association with minor facial abnormalities, short stature and ocular colobomata. In addition, patients present chondrodysplasia punctata, brachycephaly, flat facial profile with small nose, flat lower eyelids and low-set ears, developmental delay, brachytelephalangy and deep palmar creases. Complex congenital cardiac disease and central nervous system anomalies (including partial absence of corpus callosum, small vermis, enlargement of the cisterna magna and/or of the anterior horns of the lateral ventricles) have been reported.
Biomarker and diagnostic research for chondrodysplasia punctata, Toriello type has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chondrodysplasia punctata, Toriello type.
164 publications have been identified in PubMed for chondrodysplasia punctata, Toriello type. Research spans Review / Meta-Analysis (53%), Basic Science / Preclinical (18%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 87 | 53% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:33 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
30 |
18% |
Disease patterns and progression | 16 | 10% |
Patient case studies | 15 | 9% |
Testing and diagnosis research | 8 | 5% |
Clinical study results | 6 | 4% |
Other research | 2 | 1% |
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Current opinion in gastroenterology*. [Clinical Trial Publication]
Qiu XY (2026). [PMID: 41667297](https://pubmed.ncbi.nlm.nih.gov/41667297/). *J Integr Med*. [Review / Meta-Analysis]
Yacob D (2025). [PMID: 40752916](https://pubmed.ncbi.nlm.nih.gov/40752916/). *Gastroenterology clinics of North America*. [Review / Meta-Analysis]
Jachiet V (2025). [PMID: 40476413](https://pubmed.ncbi.nlm.nih.gov/40476413/). *La Revue du praticien*. [Case Report / Case Series]
Sullivan MM (2025). [PMID: 40153327](https://pubmed.ncbi.nlm.nih.gov/40153327/). *Clinical and experimental rheumatology*. [Basic Science / Preclinical]